Home
Contact
Links
PsiOxus Therapeutics
/
Links
Comments are closed.
PsiOxus in the News
PsiOxus Upcoming Events
PsiOxus Awards & Achievements
Recent Posts
PsiOxus Therapeutics Announces First-in-Human Dosing of their Second Gene Therapy Cancer Treatment.
PsiOxus Therapeutics to Collaborate with the Parker Institute for Cancer Immunotherapy
PsiOxus Therapeutics Appoints Melissa Epperly as Chief Financial Officer
PsiOxus Therapeutics Receives $15 Million Milestone Payment as Armed Oncolytic Virus Licensed to Bristol-Myers Squibb Achieves CTA
PsiOxus Therapeutics is listed in FierceBiotech’s 2017 Fierce 15
Filter Publications
Enadenotucirev Preclinical
Enadenotucirev Clinical
T-SIGn
Reviews
© Copyright 2019 PsiOxus Therapeutics
RSS
Back to Top
About
Vision & Strategy
People & Investors
Partnering
Recruitment Opportunities
Awards & Achievements
Products and Platform
Pipeline
Enadenotucirev
T-SIGn Platform
NG-348
NG-350A
NG-641
Publications
Clinical Trials
News & Events
PsiOxus in the News
Contact
Menu
Comments are closed.